In order to determine the effect of PAR4-AP on the growth of ESCC cell lines, ESCC cells were treated with PAR4-AP and cell proliferation was assessed using RTCA and MTT assay. This evidence concerns the gene F2RL3 and esophageal squamous cell carcinoma.